Growth in the behavioral health industry may look very different in 2024 than it has over the past few boom years. Gone are the days of growth for growth’s sake.
Today, providers are prioritizing targeted de novo gains and keeping their balance sheets cash-flow positive. Industry headwinds, including high rates and ongoing labor shortages, have led to many providers pulling back from M&A and looking instead to strategic organic expansion, Behavioral Health Business reports.
“The era of growth at all costs is over,” said Danish Qureshi, president and COO of LifeStance Health (Nasdaq: LFST). “I know in the public market that’s over, and I’d say in the majority of the private market that’s over as well.” Read more.
